Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | PLAU | P00749 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4404077 | 0.86 | CNR2 (0.64) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL287165 | 0.84 | RAB9A (0.56) | CNR2RAB9APLAUCYP2A6F12 | |
| Hydrochloric Acid SCHEMBL3294760 | 0.82 | RAB9A (0.55) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL22664584 | 0.82 | RAB9A (0.55) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL111310 | 0.82 | CNR2 (0.53) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL970997 | 0.82 | CNR2 (0.53) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL29358323 | 0.82 | CNR2 (0.53) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL28492272 | 0.82 | CNR2 (0.53) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL349832 | 0.82 | CNR2 (0.56) | CNR2RAB9APLAUCYP2A6F12 | |
| SCHEMBL28134671 | 0.82 | RAB9A (0.55) | CNR2RAB9APLAUCYP2A6F12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10611727-B2 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | UNIVERSITAT DE BARCELONA (ES) | 2020-04-07 | — | — | US | claimed |
| US-20190084927-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | UNIVERSITAT DE BARCELONA (ES) | 2019-03-21 | — | — | US | claimed |
| US-10125097-B2 | 1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | UNIVERSITAT DE BARCELONA (ES) | 2018-11-13 | — | — | US | claimed |
| EP-2917209-B1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | UNIV BARCELONA (ES) | 2017-02-08 | — | — | EP | claimed |
| US-20160168088-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | IPROTEOS S,L, (ES) | 2016-06-16 | — | — | US | claimed |
| EP-2917209-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | Universitat de Barcelona (ES) | 2015-09-16 | — | — | EP | claimed |
| WO-2014072498-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | UNIVERSITAT DE BARCELONA (ES) | 2014-05-15 | — | — | WO | claimed |
| EP-2730571-A1 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | Universitat De Barcelona (ES) | 2014-05-14 | — | — | EP | claimed |
| US-5021421-A | Psychotropic agents | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1991-06-04 | — | — | US | claimed |
| EP-4371979-A1 | FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| CN-117693500-A | Carboxamide derivative and agricultural/horticultural plant disease control agent | 组合化学工业株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-110997698-B | Immunomodulatory agents acting as PD-1 antagonists | 百时美施贵宝公司 | 2023-12-26 | — | — | CN | disclosed |
| WO-2023286855-A1 | FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT | クミアイ化学工業株式会社 | 2023-01-19 | — | — | WO | disclosed |
| US-10611727-B2 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | UNIVERSITAT DE BARCELONA (ES) | 2020-04-07 | — | — | US | disclosed |
| US-20160168088-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | IPROTEOS S,L, (ES) | 2016-06-16 | — | — | US | disclosed |
| EP-2917209-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | Universitat de Barcelona (ES) | 2015-09-16 | — | — | EP | disclosed |
| WO-2014072498-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | UNIVERSITAT DE BARCELONA (ES) | 2014-05-15 | — | — | WO | disclosed |
| EP-2730571-A1 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | Universitat De Barcelona (ES) | 2014-05-14 | — | — | EP | disclosed |
| US-7217723-B2 | Substituted benzothiophenes, e.g., 7Z)-7-hydroxyimino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-sulfonic acid [2-(4-fluorophenyl)-2-hydroxyethyl]-methyl-amide; treating allergies such as atopic dermatitis, allergic coryza, bronchial asthma, hypersensitive pneumoniac and pulmonary aspergillosis. | EISAI CO., LTD. (JP) | 2007-05-15 | — | — | US | disclosed |
| US-20050227959-A1 | Heterocyclic compound having oxime group | EISAI CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190084927-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | BDNF, GRIN1, NLN | CNR2 41/4885RAB9A 2238/4885PLAU 2805/4885 |
| US-10611727-B2 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | BDNF, GRIN1, NLN | CNR2 41/4885RAB9A 2238/4885PLAU 2805/4885 |
| US-10125097-B2 | 1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives | BDNF, GRIN2A, NLN | CNR2 34/4885RAB9A 2657/4885PLAU 3143/4885 |
| US-20160168088-A1 | 1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES | BDNF, GRIN2A, NLN | CNR2 34/4885RAB9A 2657/4885PLAU 3143/4885 |
| US-20050227959-A1 | Heterocyclic compound having oxime group | STAT6, HRH4, HRH2 | CNR2 165/4885RAB9A 3907/4885PLAU 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.